Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"This is an invaluable resource that allowed me to become more aware of all
of the global biotechnology outsourcing companies that are out there."
Executive Director Of Manufacturing and Science Technology; Biotechnology, Asia  
BioProcess International Conference
September 16-20 Boston, MA |
Catalent Pharma Solutions, Inc. Cirrus Pharmaceuticals DPT Laboratories, Ltd. Frontage Laboratories, Inc. Lyophilization Technology, Inc. Corden Pharma International GmbH Quay Pharmaceuticals Therapure Biopharma, Inc. ExxPharma Therapeutics LLC
ExxPharma Therapeutics LLC is a specialty pharmaceutical development company that utilizes innovative formulation and manufacturing technologies to develop high quality oral solid dosage forms intended for all stages of clinical development and commercial production. Its technologies integrate proprietary drug delivery systems and cutting-edge manufacturing processes to solve technically challenging development projects. Company projects include formulation of poorly soluble drug substances; development of modified release drug products; formulation of heat or moisture sensitive drug substances; development of ultra low or very high dose drug products; and co-formulation of incompatible fixed-dose combination dosage forms. http://www.exxpharma.com
Regions
Americas Stock Symbol Private Filter of ExxPharma Therapeutics LLC's services per Nice Insight Categories
Contact ExxPharma Therapeutics LLC 
|
|
|
